A Pilot Dosing and Timing Study to Optimize Imaging When Utilizing Endoscopic Fluorescence Imaging System During Laparoscopic Biliary and Hepatic Operations
Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
University of California, Los Angeles
With
Novadaq Technologies ULC, now a part of Stryker
Age
18–any
Sex
ALL
Healthy volunteers
Accepted
You may be eligible if
To be eligible for the study, subjects must fulfill all of the following criteria:
1. Subjects who are healthy men or women 18 years of age or older.
2. Subjects who are scheduled for laparoscopic biliary or hepatic operations.
3. Subjects who sign an approved informed consent form for the study.
4. Subjects who are willing to comply with the protocol.
You may not be if
Subjects meeting any of the following criteria will be excluded from the study:
1. Subjects with a known allergy or history of adverse reaction to ICG, iodine or iodine dyes.
2. Subjects who, in the Investigator's opinion, have any medical condition that makes the subject a poor candidate for the investigational procedure, or interferes with the interpretation of study results.
3. Subjects who are pregnant or lactating females.
4. Subjects, who are actively participating in another investigational clinical study and who, in the Investigator's or Sponsor's opinion, should not be enrolled in this study.
Clareo Health | A Pilot Dosing and Timing Study to Optimize Imaging When Utilizing Endoscopic Fluorescence Imaging System During Laparoscopic Biliary and Hepatic Operations
